Hana Pharm Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 1.10%

Hana Pharm Co Ltd (293480) has an Asset Resilience Ratio of 1.10% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hana Pharm Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩4.91 Billion
≈ $3.33 Million USD Cash + Short-term Investments

Total Assets

₩446.69 Billion
≈ $302.72 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Hana Pharm Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Hana Pharm Co Ltd.

Liquid Assets Composition Over Time

This chart breaks down Hana Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 293480 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩4.91 Billion 1.1%
Total Liquid Assets ₩4.91 Billion 1.10%

Asset Resilience Insights

  • Limited Liquidity: Hana Pharm Co Ltd maintains only 1.10% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hana Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Hana Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Kamada
TA:KMDA
Drug Manufacturers - Specialty & Generic 0.00%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.48%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
Drug Manufacturers - Specialty & Generic 1.01%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%

Annual Asset Resilience Ratio for Hana Pharm Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Hana Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.87% ₩3.63 Billion
≈ $2.46 Million
₩418.14 Billion
≈ $283.37 Million
-0.08pp
2024-12-31 0.95% ₩3.64 Billion
≈ $2.47 Million
₩382.01 Billion
≈ $258.88 Million
-0.41pp
2023-12-31 1.36% ₩4.73 Billion
≈ $3.21 Million
₩348.39 Billion
≈ $236.10 Million
-0.10pp
2022-12-31 1.46% ₩5.03 Billion
≈ $3.41 Million
₩345.96 Billion
≈ $234.46 Million
-15.10pp
2021-12-31 16.56% ₩50.25 Billion
≈ $34.05 Million
₩303.50 Billion
≈ $205.68 Million
-2.54pp
2020-12-31 19.10% ₩52.83 Billion
≈ $35.80 Million
₩276.58 Billion
≈ $187.43 Million
-9.19pp
2019-12-31 28.29% ₩74.42 Billion
≈ $50.44 Million
₩263.03 Billion
≈ $178.25 Million
-8.56pp
2018-12-31 36.85% ₩89.32 Billion
≈ $60.53 Million
₩242.38 Billion
≈ $164.26 Million
+34.34pp
2017-12-31 2.51% ₩3.55 Billion
≈ $2.41 Million
₩141.55 Billion
≈ $95.93 Million
+0.96pp
2016-12-31 1.54% ₩1.77 Billion
≈ $1.20 Million
₩114.59 Billion
≈ $77.66 Million
--
pp = percentage points

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$98.97 Million
₩146.04 Billion KRW
Market Cap Rank
#19321 Global
#956 in Korea
Share Price
₩8240.00
Change (1 day)
-0.96%
52-Week Range
₩8240.00 - ₩12290.00
All Time High
₩26028.86
About

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and an… Read more